| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BB Brian Baylis Bell Investment Advisors Inc. | 248 | $451.36 | $138.88 | -$312.48 | -69.23% |
| Health Care Equipment & Supplies Industry | Healthcare Sector | Yen Feng Chhoa CEO | NASDAQ (CM) Exchange | G0864B103 CUSIP |
| SG Country | 32 Employees | - Last Dividend | 22 Jun 2026 Last Split | - IPO Date |
Basel Medical Group Ltd is a dynamic healthcare provider established in 2023. Headquartered in Singapore, the company specializes in a broad range of healthcare services aimed at enhancing patient care and accessibility. Basel Medical Group is dedicated to offering innovative solutions across several medical domains, including medical specialist services, medical supplies and equipment, medical technology advancements, and pharmaceuticals. With a commitment to advancing healthcare standards, the company strives to support both healthcare providers and patients in achieving better health outcomes.
Basel Medical Group collaborates with a network of experienced medical specialists across various fields. These experts provide comprehensive consultations and treatment options tailored to meet the needs of patients, ensuring quality care in areas such as cardiology, pediatrics, orthopedics, and more.
The company offers a wide array of medical supplies and equipment essential for healthcare operations. This includes surgical instruments, diagnostic tools, and various medical consumables, all sourced from reputable manufacturers to guarantee reliability and safety for healthcare providers and their patients.
Basel Medical Group is focused on incorporating cutting-edge medical technology into its services. This includes advanced health information systems, telemedicine solutions, and innovative medical devices that enhance diagnostic accuracy and treatment effectiveness, thereby streamlining healthcare delivery.
The company provides a comprehensive range of pharmaceutical products, offering everything from over-the-counter medications to prescription drugs for various health conditions. Basel Medical Group emphasizes the importance of quality control and regulatory compliance in its pharmaceutical services, ensuring that all products meet the highest safety standards.